Byrn, Inc. (BRRN) — Current Report

Key Insights

• MEDO Healthcare LLC acquired 84.7% voting control of Bryn Inc. by purchasing 10 million Series A-1 Preferred Shares for only $175,000, representing an extreme valuation discount and indicating severe financial distress or a restructuring transaction.
• Complete management change occurred with founder David Lazar resigning as sole director and officer, replaced by John Leo (CEO) and Arthur Magee (CFO/Secretary), suggesting strategic repositioning under new leadership with significant financial services and investment banking experience.
• The transaction reflects a change of control event where voting power shifted dramatically from Lazar (previously sole control) to MEDO Healthcare (84.7% voting power), with actual operational control held by Miriam Mizrachi as Manager of Ashford Capital LLC.
• John Leo's appointment as CEO brings extensive experience in investment banking, M&A, and capital markets across 100+ U.S. and 50+ foreign companies, along with recent executive experience at a financial institution, suggesting potential strategic repositioning or acquisition activity ahead.